Low-dose atropine eye drops slow myopia progression in children

Scientists have found that low-dose atropine eye drops can slow the worsening of myopia in children. A study published in The BMJ tested this treatment over three years and discovered it reduced myopia progression by 50 to 77 percent compared to children who received no treatment.

Myopia, or nearsightedness, is becoming increasingly common in children worldwide. Previous research used stronger atropine drops, but these caused problems like enlarged pupils and blurred vision. The new low-dose version avoids these side effects while remaining effective.

Doctors applied the eye drops once daily to children aged 4 to 14. The 0.05 percent concentration proved most successful among the lower doses tested. Researchers used a formulation without preservatives to ensure safety. This practical treatment could help children avoid needing stronger glasses as they grow.